“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs

Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis

(2020) Rodolfo Castro et al.   PLoS One

Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)

(2020) Marion Mora et al.   JOURNAL OF VIRAL HEPATITIS

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐ SCOPE Study

(2019) Alain H. Litwin et al.   JOURNAL OF VIRAL HEPATITIS

The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals

(2019) Sofia R. Bartlett et al.   LIVER INTERNATIONAL

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

(2019) Evan B Cunningham et al.   CLINICAL INFECTIOUS DISEASES

Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting

(2018) Arshia Alimohammadi et al.   Open Forum Infectious Diseases

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

(2018) Jason Grebely et al.   ADDICTION

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort

(2018) Carmine Rossi et al.   JOURNAL OF HEPATOLOGY

Addressing Intersecting Housing and Overdose Crises in Vancouver, Canada: Opportunities and Challenges from a Tenant-Led Overdose Response Intervention in Single Room Occupancy Hotels

(2018) Geoff Bardwell et al.   JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE

How Equity‐Oriented Health Care Affects Health: Key Mechanisms and Implications for Primary Health Care Practice and Policy

(2018) MARILYN FORD‐GILBOE et al.   MILBANK QUARTERLY

High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs

(2017) ME Socías et al.   HIV MEDICINE

Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs

(2016) Alice K. Asher et al.   SUBSTANCE USE & MISUSE

Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993–2011

(2015) Margot Kuo et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs

(2015) Anthony Cousien et al.   HEPATOLOGY

Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting

(2013) Magdalena Harris et al.   SOCIAL SCIENCE & MEDICINE

The social production of hepatitis C risk among injecting drug users: a qualitative synthesis

(2008) Tim Rhodes et al.   ADDICTION